The Minnesota UDCA Clinical Study

The Minnesota UDCA Clinical Study
Researchers in Minnesota (USA) have recently published the results of a small pilot clinical trial investigating the safety of Ursodeoxycholic acid (or UDCA) in Parkinson's. Currently UDCA is used to treat gallstones but research has gradually been building that suggests this medication could potentially be a useful treatment for Parkinson's.  UDCA is a naturally occurring bile acid, which helps to ... read more
Source: The Cure Parkinson’s TrustPublished on 2020-02-20